United States
Print page content Print
Increase text size Decrease text size
Text Size

VANGUARD® CV

Helps deliver protection against canine coronavirus

VANGUARD CV

VANGUARD CV is recommended for vaccination of healthy dogs 6 weeks of age or older to help prevent canine coronaviral gastroenteritis.

Expand All
    • Safety of Vanguard CV was assessed in a field trial in which 5,999 doses were administered.
    • Highly specialized vaccine allows for tailored protocols.
    • In an efficacy study, vaccinated puppies demonstrated significant differences in reduction of clinical signs, virus shed and reduction of diarrhea post-challenge when compared with the control group.
    • Covered by the Companion Animal Immunization Support Guarantee.
  • DIRECTIONS:

    1. General Directions: Vaccination of healthy dogs is recommended. Shake well. Aseptically administer 1 mL subcutaneously or intramuscularly.

    2. Primary Vaccination: Healthy dogs 6 weeks of age or older should receive 2 doses administered 2-3 weeks apart. If dogs are vaccinated before the age of 4 months, they should be revaccinated with a single dose upon reaching 4 months of age. (Maternal antibodies may interfere with development of an adequate immune response in puppies less than 4 months old.)

    3. Revaccination: Annual revaccination with a single dose is recommended.
     


PRECAUTIONS:

1. Store at 2°-7°C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze.

2. Use entire contents when first opened.

3. Contains gentamicin as preservative.

4. Vaccination of pregnant bitches should be avoided.

5. As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.

6. This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

Technical inquiries should be directed to Zoetis Veterinary Services, (800) 366-5288 (USA), (800) 461-0917 (Canada).

For veterinary use only.